Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, California.
Department of Otolaryngology-Head and Neck Surgery, Stanford University, Palo Alto, California.
Clin Cancer Res. 2019 Jun 15;25(12):3528-3537. doi: 10.1158/1078-0432.CCR-18-4085. Epub 2019 Mar 4.
To identify immune subtypes and investigate the immune landscape of squamous cell carcinomas (SCC), which share common etiology and histologic features.
Based on the immune gene expression profiles of 1,368 patients with SCC in the Cancer Genome Atlas (TCGA), we used consensus clustering to identify robust clusters of patients and assessed their reproducibility in an independent pan-SCC cohort of 938 patients. We further applied graph structure learning-based dimensionality reduction to the immune profiles to visualize the distribution of individual patients.
We identified and independently validated six reproducible immune subtypes associated with distinct molecular characteristics and clinical outcomes. An immune-cold subtype had the least amount of lymphocyte infiltration and a high level of aneuploidy, and these patients had the worst prognosis. By contrast, an immune-hot subtype demonstrated the highest infiltration of CD8 T cells, activated NK cells, and elevated IFNγ response. Accordingly, these patients had the best prognosis. A third subtype was dominated by M2-polarized macrophages with potent immune-suppressive factors such as TGFβ signaling and reactive stroma, and these patients had relatively inferior prognosis. Other subtypes showed more diverse immunologic features with intermediate prognoses. Finally, our analysis revealed a complex immune landscape consisting of both discrete clusters and continuous spectrum.
This study provides a conceptual framework to understand the tumor immune microenvironment of SCCs. Future work is needed to evaluate its relevance in the design of combination treatment strategies and guiding optimal selection of patients for immunotherapy.
鉴定鳞状细胞癌(SCC)的免疫亚型并研究其免疫全景,这些肿瘤具有共同的病因和组织学特征。
基于癌症基因组图谱(TCGA)中 1368 例 SCC 患者的免疫基因表达谱,我们使用共识聚类来鉴定稳健的患者聚类,并在 938 例独立的泛 SCC 队列中评估其重现性。我们进一步将基于图结构学习的降维方法应用于免疫谱,以可视化个体患者的分布。
我们鉴定并独立验证了与独特分子特征和临床结局相关的六个可重现的免疫亚型。免疫冷亚型的淋巴细胞浸润最少,非整倍体水平较高,这些患者预后最差。相比之下,免疫热亚型表现出最高水平的 CD8 T 细胞、活化的 NK 细胞浸润和 IFNγ 反应,这些患者的预后最好。因此,这些患者的预后最好。第三种亚型以 M2 极化的巨噬细胞为主,具有强大的免疫抑制因子,如 TGFβ 信号和反应性基质,这些患者的预后相对较差。其他亚型则表现出更具异质性的免疫特征,预后处于中间水平。最后,我们的分析揭示了一个由离散聚类和连续谱组成的复杂免疫全景。
这项研究为理解 SCC 的肿瘤免疫微环境提供了一个概念框架。未来需要进一步研究其在联合治疗策略设计和免疫治疗患者最佳选择中的相关性。